Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
ProShares Ultra CRCL (CRCA) Down -54% Over 30 Days: What’s Behind the Move

ProShares Ultra CRCL (CRCA) Down -54% Over 30 Days: What’s Behind the Move

Key Takeaways

  • CRCA is a leveraged exchange-traded fund (ETF) that seeks 2x the daily return of Circle Internet Group (CRCL), the issuer of the USDC stablecoin.
  • Over the last 30 days, CRCA has declined roughly 54%, from about $16.90 to about $7.84, reflecting a sharp sell-off in the underlying stock amplified by daily leverage.
  • Over the last quarter, the fund is down approximately 52%, extending a sustained downtrend from its mid-August levels.
  • The primary catalysts are falling interest rates, which compress Circle's reserve income, rising stablecoin competition, and a recent workforce reduction.
  • Because CRCA resets its 2x exposure daily, it is also subject to volatility decay, which can amplify losses during choppy, downtrending markets.
  • The single most influential driver is concentrated exposure to CRCL, whose earnings model is closely tied to short-term U.S. Treasury yields.
  • For additional detail on this ticker's Price Targets and Forecast, explore the dedicated analysis pages for more context.
  • Investors seeking automated idea generation can also explore Trending AI Robots for AI-driven trading signals.

Understanding CRCA’s Structure and Single-Stock Exposure

CRCA is a single-stock leveraged ETF managed by ProShares, the largest provider of leveraged and inverse ETFs. The fund seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of Circle Internet Group, Inc. (NYSE: CRCL), the financial technology company behind the USDC stablecoin.

Rather than holding a diversified basket, the fund concentrates its exposure on a single underlying security, using total return swaps with multiple counterparties to achieve its leveraged objective. In practice, its portfolio is effectively 100% tied to the price of CRCL, with the remainder held as cash and collateral. The fund is non-diversified and carries a net expense ratio of 0.95%.

This concentrated, leveraged structure explains why CRCA's ETF performance is so volatile. Because the underlying stock has been in a steep downtrend, the daily 2x reset has magnified those losses, while the compounding effect of daily rebalancing has added further drag during sustained, choppy declines. When assessing similar products, I sometimes cross-check sector momentum with Tickeron’s AI Screener to see how CRCA stacks up against peers.

CRCA Price Performance: Last 30 Days Compared to the Quarter

CRCA's recent price movement has been sharply negative and trend-driven rather than range-bound. Approximately 30 days ago, the fund traded near $16.90 per share. As of the latest available session, it was near $7.84, representing a decline of roughly 54% over the period.

The quarterly picture is similarly weak. From roughly $16.50 in mid-August, CRCA has fallen approximately 52%. This trajectory reflects both the decline in the underlying CRCL stock and the mathematical effect of daily leverage. In a falling market, a leveraged fund can lose more than twice the underlying's percentage decline over multi-day periods, because each day's reset compounds from a lower base.

Drivers Behind the Last 30 Days of Performance

The dominant driver of CRCA's ETF price movement has been a sell-off in Circle Internet Group shares. Circle generates roughly three-quarters of its revenue from interest earned on the cash and short-term U.S. Treasuries that back USDC. As the Federal Reserve has cut interest rates, the yield on those reserves has fallen, directly compressing Circle's core earnings.

In its most recent quarterly results, Circle reported that reserve income declined 8% year over year, with the return rate on reserves falling 61 basis points to 3.5%. Although total revenue rose, the increase was driven largely by a one-time token presale, while the underlying reserve business decelerated. Circle also disclosed a reduction of about 5% of its workforce, underscoring cost pressures tied to the lower-rate environment.

Competitive dynamics have added further pressure. New yield-sharing stablecoin initiatives backed by large payment and financial firms have raised questions about USDC's long-term market position. USDC circulation ended the latest quarter at roughly $73.9 billion, flat year over year, while its share of the dollar stablecoin market slipped to about 27%.

Factors Shaping Performance Over the Last Quarter

The three-month trend reflects a broader repricing of Circle's business model. Beyond the near-term earnings catalysts, investors have reassessed the sustainability of reserve-based income as interest rates normalize, alongside rising competition from bank-issued and yield-sharing stablecoins.

Regulatory developments have also shaped sentiment. U.S. stablecoin legislation and related rulemaking have introduced uncertainty around reserve income and distribution economics. Combined with the post-IPO lockup expiration that created incremental selling pressure in the underlying stock, these factors have sustained a downward bias in CRCL that CRCA's leverage has mechanically amplified. The absence of meaningful diversification means the fund has had no offsetting sector or factor exposure to cushion the decline.

Outlook: What to Watch Going Forward

Going forward, the factors most likely to influence CRCA are those affecting Circle's fundamentals and the broader interest-rate environment. The path of Federal Reserve policy remains central: additional rate cuts would further compress Circle's reserve income, while a pause or a firmer yield backdrop could ease that pressure.

Investors should also monitor USDC circulation trends and stablecoin market share, competitive product launches from payment networks and banks, and the implementation of U.S. stablecoin regulation. Circle's efforts to diversify revenue through payments infrastructure and its Arc blockchain will be important to whether earnings become less sensitive to rates. Finally, because CRCA is a leveraged, daily-reset product, its performance can diverge meaningfully from the underlying stock over time, making volatility decay and holding-period mechanics key considerations for anyone evaluating the fund.

Using Tickeron’s AI Screener for Deeper Research

I’ve found Tickeron’s AI Screener helpful when evaluating leveraged single-stock ETFs like CRCA. The platform lets me scan thousands of securities with technical indicators, fundamentals, volatility metrics, price patterns, and AI-generated signals. It surfaces potential comparables and momentum trends efficiently, which adds useful context when reviewing concentrated products in a volatile sector. This kind of structured screening supports a more systematic approach to idea generation without replacing individual analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CRCA

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


Momentum Indicator for CRCA turns negative, indicating new downward trend

CRCA saw its Momentum Indicator move below the 0 level on October 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator turned negative. In 22 of the 24 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CRCA turned negative on October 27, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 8 similar instances when the indicator turned negative. In 8 of the 8 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRCA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for CRCA entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +11.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRCA advanced for three days, in 50 of 57 cases, the price rose further within the following month. The odds of a continued upward trend are 88%.

CRCA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of Class A common shares of Circle Internet Group, Inc. (NYSE Arca: CRCL). Under normal circumstances, the fund will invest at least 80% of the fund's assets in, or provide exposure to, financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the daily target. The fund is non-diversified.
Trend Prediction Engine 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
NVIDIA shares declined roughly 26% over the 30 days ending mid-November, falling from a close near $221 to $162.85. The drop left the stock about 30% below its October 6 record intraday high of $243.37 and at a 52-week low.
ACHR fell -7.44% in Monday's regular session, sliding from Friday's $4.03 close to $3.73 shortly after 10 a.m. ET — a third consecutive daily decline that pushed shares back toward their November 5 low. No verified news or fundamental catalyst found for today's leg lower; the selling extends the de-rating that followed Q3 results — revenue of just $5.1 million, a net loss widening 111% to $274.6 million, and price-target cuts from Cantor Fitzgerald, Needham and Canaccord.
Micron shares fell -6.28% to $729.40 from Friday's $778.31 close, gapping lower in premarket trading and holding those losses into Monday's regular session. The decline was sector-driven, not company-specific: memory peers SanDisk, SK hynix and Western Digital slid in tandem as last week's Nvidia CEO departure revived doubts over AI data-center spending, financing and memory demand durability.
Dell Technologies (DELL) fell roughly 23.7% over the last 30 days, sliding from a closing price of $451.71 on October 16, 2026, to $344.53 on November 13, 2026. The decline accelerated after the U.S. midterm elections, when investor concerns about potential AI and data-center regulation triggered a sharp sell-off across AI hardware names.
SKHY fell -6.87% to $122.74 by 10:04 a.m. ET, down $9.05 from Friday's close of $131.79, extending a premarket decline into the regular session. The drop was driven by a sector-wide AI chip selloff ahead of Nvidia's quarterly results on Tuesday, where CEO Jensen Huang's resignation has raised doubts about the durability of data-center spending that underpins high-bandwidth memory demand.